Research findings suggest structured interdisciplinary rounds may help reduce the number of adverse events in the hospital setting, according to a study published in the Archives of Internal Medicine.
The structured interdisciplinary rounds combined a structured format for communications with a forum for regular interdisciplinary meetings. Researchers assessed the impact of the interdisciplinary rounds on 185 control patients (concurrent control) and 185 intervention patients admitted 24 weeks after the implementation. Researchers also studied 185 patients (historic control) admitted 24 weeks before implementation of the rounds.
Results of their study showed the rate of adverse events was 3.9 per 100 patient days for intervention patients, compared with 7.2 and 7.7 per 100 patient days for concurrent and historic control patients. Similarly, the rate of preventable adverse events was 0.9 per 100 patient days for intervention patients, compared with 2.8 and 2.1 per 100 patient days for concurrent and historic control patients.
Read the study about structured interdisciplinary rounds.
Read other coverage about adverse events:
- 20 Questions Surgery Centers Should Ask to Ensure an Effective Safe Medication Management Program
- University of Maryland: FDA Adverse Drug Reports Boomed in Last Decade
- 5 Tools to Improve Patient Safety
The structured interdisciplinary rounds combined a structured format for communications with a forum for regular interdisciplinary meetings. Researchers assessed the impact of the interdisciplinary rounds on 185 control patients (concurrent control) and 185 intervention patients admitted 24 weeks after the implementation. Researchers also studied 185 patients (historic control) admitted 24 weeks before implementation of the rounds.
Results of their study showed the rate of adverse events was 3.9 per 100 patient days for intervention patients, compared with 7.2 and 7.7 per 100 patient days for concurrent and historic control patients. Similarly, the rate of preventable adverse events was 0.9 per 100 patient days for intervention patients, compared with 2.8 and 2.1 per 100 patient days for concurrent and historic control patients.
Read the study about structured interdisciplinary rounds.
Read other coverage about adverse events:
- 20 Questions Surgery Centers Should Ask to Ensure an Effective Safe Medication Management Program
- University of Maryland: FDA Adverse Drug Reports Boomed in Last Decade
- 5 Tools to Improve Patient Safety